FDA 483 - Elysium Pharmaceuticals Limited - January 16, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Elysium Pharmaceuticals Limited in Vadodara, India, revealed significant deficiencies across laboratory controls, facility maintenance, and production record-keeping. Observations included unrecorded deviations from test procedures, incomplete laboratory data, water system leaks, inadequate equipment cleaning, and missing documentation of personnel actions in batch records. These issues indicate a lack of adherence to good manufacturing practices.
ID · d3c9a254-7ccd-4b13-b5e1-b296f0d7a521